This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

II. RELATION BETWEEN SUBCLINICAL INFLAMMATORY PROCESSES AND CARCINOMA

J. ARNOLD BARGEN, M.D.; COLIN D. L. CROMAR, M.B., F.R.C.S. (Edin.); CLAUDE F. DIXON, M.D.

Arch Surg. 1941;43(2):192-208.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

It is now generally agreed that a cancer represents the ultimate phase of a definite series of changes rather than a mere fortuitous incident in the life of the tissues, and, although the nature of these changes is not yet completely understood, it is known that they result from developmental change, from reaction to prolonged irritation or from unsuccessful attempts at tissue repair. Evidence giving support to this has been accumulated by investigators in three separate fields—experimental workers, pathologists and clinicians.

EXPERIMENTAL WORK

Experiments have been carried out chiefly on the so-called tar cancer in mice. Cramer,¹ by applying one of the known carcinogenic substances to the skin of mice, was able to produce typical epithelioma in these animals. He observed that the process is not continuous but is composed of two phases: (a) a process of long duration inducing in the cells a condition of "potential" malignancy which . . . [Full Text PDF of this Article]

Author Affiliations
Fellow in Surgery, the Mayo Foundation; ROCHESTER, MINN.

From the Division of Medicine (Dr. Bargen) and the Division of Surgery (Dr. Dixon), the Mayo Clinic.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?